| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.2 |